The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Hoping to hit a $200M target, NCI and FNIH develop a plan for advancing cancer vaccines
NCI Director Letai: “How aggressive can we be?”

Cancer Policy

The reconstitution of ACIP and changes to CDC’s childhood vaccine schedule were likely illegal, judge rules

EPA proposes amendments to weaken emission limits on ethylene oxide

FDA launches consolidated adverse event reporting system

House bill proposes to exempt health care workers from H-1B visa $100,000 fee

HHS postpones third USPSTF meeting in a row

FDA approves leucovorin for cerebral folate deficiency

Clinical Roundup

Merck to present long-term data of Gardasil 9 and Gardasil at the EUROGIN international multidisciplinary HPV Congress

Atirmociclib combination produces positive topline results in phase II trial in second-line MBC indication

Mayo Clinic researchers use milk-derived nanoparticles to target aggressive bile duct cancer

Computational model measures key aging metric from routine biopsies, Sanford Burnham study finds

Computational biology tool automates and standardizes genome sequencing analysis, Sanford Burnham study finds

Inocras and Broad Institute researchers will release insights from TCGA cancer whole-genome analysis at AACR annual meeting

In The Clinic
Trials & Tribulations

Why infection and immunity matter for Florida’s cancer patients

FreeTrials & Tribulations
News Analysis
Health Equity
Latest Issue
Read the latest issue
Read the latest issue
DOWNLOAD THE PDF
UPCOMING EVENTS
Mar 2026
27
NCCN 2026 Annual Conference
May 2026
29
2026 ASCO Annual Meeting
Jun 2026
25
MASCC/ISOO 2026 Annual Meeting
View All Events

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account